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Abnormal relationship between sodium intake and sympathetic nervous
system activity in salt-sensitive patients with essential hypertension. To
examine the mechanisms underlying the sensitivity to sodium intake in
a subset of patients with essential hypertension, we studied the effects
of different sodium intake (10, 100, 200 mEq/day) on blood pressure, the
function of the renin-angiotensin-aldosterone system, and on blood
levels of catecholamines in 20 patients with essential hypertension and
10 normal subjects. Mean blood pressure (MBP) was not different in
hypertensive and normal subjects during low sodium diet. But, with
high sodium intake, MBP increased by at least 10% in 12 patients (salt-
sensitive), whereas in the remaining 8 patients (salt-resistant) and in
normal subjects, MBP did not change significantly. This phenomenon
cannot be attributed to differences in sodium retention because the
percent change in body weight and the urinary sodium excretion in the
salt-sensitive patients was not different than it was in salt-resistant
patients or in normal subjects. The observed difference in blood
pressure response to high sodium intake in salt-sensitive patients is also
not dependent on an impaired suppressibility of the renin-angiotensin-
aldosterone system because there were no significant differences in the
basal levels of PRA and aldosterone between the groups, and because
the orthostatic increments in PRA were significantly lower in salt
sensitive than they were in the salt-resistant patients and in normal
subjects. Plasma norepinephrine (NE) levels were not significantly
different between normal subjects or hypertensive patients while on low
sodium intake. But during high sodium intake, they decreased signifi-
cantly (P < 0.05) in normal subjects (from 22 3.4 to 12 2.3 ng/dl)
and in salt-resistant patients (from 17 4.5 to 13 2.4 ng/dl) but not in
salt-sensitive patients (from 20 1.9 to 22 3.2 ngldl). Furthermore,
the majority of salt-sensitive patients displayed inappropriately high
plasma NE in relation to their urine excretion of sodium during high
sodium intake. Finally, the increments in plasma NE after 5 mm of
standing were significantly greater in salt-sensitive patients than they
were in salt-resistant patients and normal subjects during both low or
high sodium intake. These data indicate that a subset of patients with
essential hypertension may have impaired suppressibility of plasma NE
during high sodium intake, which suggests hyperactivity of the sympa-
thetic nervous system in these patients. These aberrations may be
responsible for the increase in MBP in the salt-sensitive patients during
high sodium intake.
Relation anormale entre l'ingestion de sodium et I'activité du système
nerveux sympathique chez les malades atteints d'hypertension essentielle
sensibles au sel. Afin d'étudier les mécanismes qui sous-tendent Ia
sensibilité a l'apport de sodium dans un sous-groupe de malades atteints
d'hypertension essentielle, les effets de différents apports de sodium
(10, 100, 200 mEq/jour) sur Ia pression artérielle, Ia fonction du système
renine-angiotensine-aldostérone, et les concentrations sanguines de
catécholamines ont été évaluées chez 20 malades atteints d'hyperten-
sion essentielle et chez 10 sujets normaux. La pression artérielle
moyenne (MBP) n'était pas différente chez les malades hypertendu et
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les sujets normaux recevant une alimentation pauvre en sodium. Mais,
avec Ic régime riche en sodium, MBP a augmenté d'au moms 10% chez
12 malades (sensibles au sel) alors que chez les autres 8 malades
(résistants au sel) et chez les sujets normaux MBP n'a pas change de
facon significative. Ce phénomène ne peut pas ètre attribué a des
differences de retention de sodium parce que le pourcentage de modifi-
cations du poids corporel et l'excrétion urinaire de sodium chez les
malades sensibles au sd ne sont pas differents de ceux observes chez
les malades résistants au sel ou chez les sujets normaux. La difference
de pression artérielle observée chez les malades sensibles au sel au
cours de l'alimentation riche en sodium n'est pas non plus dépendante
d'une alteration du freinage du système renine-angiotensine-aldostér-
one parce qu'il n'a pas été observe de differences significatives dans les
concentrations basales de PRA et d'aldostérone entre les groupes, et
parce que l'augmentation orthostatique de PRA était significativement
plus faible chez les malades sensibles au sel que chez les malades
rCsistants au sel et les sujets normaux. Les concentrations plasmatiques
de Ia norépmnéphrine (NE) n'étaient pas significativement différentes
entre les sujets normaux et les malades hypertendus soumis a un régime
pauvre en sel. Mais, au cours du régime riche en sd us ont diminué
significativement (P < 0,05) chez les sujets normaux (de 22 3,4 a 12
2,3 ng/dl) et chez les malades résistants au sel (de 17 4,5 a 13 2,4
ng/dl) mais non chez les malades sensibles au sel (de 20 1,9 a 22 3,2
ng/dl). De plus, Ia majoritC des malades sensibles au sel ont eu une
concentration plasmatique de NE élevée de facon inappropriée par
rapport a leur excretion urinaire de soçlium au cours du régime riche en
sel. Enfin, les augmentations de NE plasmatique après 5 mm de
position debout ont etC significativement plus grandes chez les malades
sensibles au sd que chez les malades résistants au sel et les sujets
normaux aussi bien au cours du régime riche que du régime pauvre en
sodium. Ces résultats indiquent qu'un sous-groupe de malades atteints
d'hypertension essentielle peut avoir une alteration du freinage de Ia
NE plasmatique au cours de l'ingestion d'un régime riche en sodium ce
qui suggére une hyperactivité du système nerveux sympathique chez
ces malades. Ces dCsordres peuvent être responsables de l'augmenta-
tion de MBP chez les malades sensibles au sel au cours de l'ingestion
d'une régime riche en sodium.
Available evidence suggests that hypertension is related to
sodium ingestion both in man and animals [1—4]. A number of
epidemiologic studies have shown a direct relationship between
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dietary sodium intake and the incidence of hypertension [3, 5,
6]. It is also well known that sodium restriction results in
reduction of blood pressure in the great majority of patients
with essential hypertension [4, 5]. Kawasaki et al [7] identified
two subgroups of patients with essential hypertension, with one
displaying an increase in blood pressure during sodium loading
("salt sensitive"), while in the other blood pressure remains
unchanged ("nonsalt sensitive"). Furthermore, certain strains
of rats also demonstrate this phenomenon. The DahI's "S" (salt
sensitive) rats become hypertensive only when their intake of
sodium is high; in contrast, the "R" (salt-resistant) rats remain
normotensive irrespective of the amount of sodium in their diet
[8].
The mechanisms underlying the sensitivity of sodium intake
in a segment of the patients with essential hypertension have
not been fully elucidated. Thus, we studied 20 patients with
essential hypertension and 10 normal subjects in an effort to
evaluate the effects of alteration in sodium intake on blood
pressure, the function of the renin-angiotensin-aldosterone
axis, and blood levels of catecholamines.
Methods
Ten normal subjects aged 30 to 53 years (41 [SEMI 3 yr) and
20 patients with essential hypertension aged 32 to 61 years (48
2 yr) were studied. All normal subjects were white males, but
the hypertensive patients included 9 females and 11 males (12
white, 7 black, and 1 oriental). Patients were considered to have
hypertension if during three subsequent visits to the Outpatient
Clinic, their blood pressure was found to be equal to or greater
than 140/90 mm Hg. Antihypertensive medications were with-
held at least 4 weeks prior to the study. Females on birth-
control pills were excluded from the study. A diagnosis of
secondary hypertension was adequately ruled out by the find-
ings of normal SMA-12, urinalysis, electro-cardiogram, chest x-
rays, plasma aldosterone, rapid sequence i.v. pyelography, and
normal renal angiogram when clinically indicated. Normal
subjects had negative medical history, normal physical exami-
nation, and normal SMA-12, urinalysis, and creatinine clear-
ance. After the nature and the purpose of the study were
explained, an informed consent was obtained.
The subjects were admitted to the Clinical Research Center
of the Los Angeles County-University of Southern California
Medical Center for a period of 3 weeks. Throughout the study,
the subjects ingested the same basic diet containing constant
amounts of protein (1.3 g/kg), calories (30 cal/kg), and potassi-
um (80 mEq/day), whereas their sodium intake varied, During
the 3 weeks of the study, each subject received three regimens
of sodium intake (10, 100, or 200 mEq/day), with each regimen
given for 1 week. The sequence of the three sodium intakes was
randomly assigned. The subjects were weighed daily at 8:00
A.M., after they had voided and before their breakfast. Twenty-
four hour urine collections were obtained daily throughout the
study for measurement of creatinine, sodium, and potassium
excretion. It was apparent that the subjects achieved sodium
balance by day 6 of each regimen. On day 7 of each of the three
periods of the study, the subjects assumed the recumbent
position between 0600 and 0700 A.M., and a venous catheter
was inserted into a vein. One hour later, blood pressure was
measured, and a blood sample was obtained for the determina-
tion of serum sodium, potassium, creatinine, hematocrit, plas-
ma catecholamines, aldosterone, and plasma renin activity
(PRA). The subjects then assumed upright posture and re-
mained standing for 20 mm, followed by 40 mm of ambulation.
After 5, 10, 15, and 20 mm of passive orthostasis and 40 mm of
ambulation, blood pressure was measured and the blood sam-
ples were withdrawn for the determination of plasma catechol-
amines, aldosterone, and PRA.
Blood pressure measurements were made with an automatic
recorder (Physiometric SR2, Sphygmetrics Inc. Woodland
Hills, California). Each data point of blood pressure is the mean
of three consecutive readings. Mean blood pressure (MBP) was
calculated as the sum of diastolic blood pressure and one third
of pulse pressure. Sodium and potassium were determined by
Instrumentation Laboratory flame photometer (Lexington,
Massachusetts), and creatinine was measured with the Techni-
con autoanalyzer (Technicon Corp., Ardsley, New York).
Plasma norepinephrine (NE) and epinephrine (E) concentra-
tions were determined by the radioenzymatic method of Da-
Prada et al [9], using the enzyme catechol-o-methyl transferase
prepared according to the method of Axelrod and Tomchick
[10] and a methyl-donor, 3H-methyl-S-adenosine-methionine
(New England Nuclear, Boston, Massachusetts). The sensitiv-
ity of this method is 1 pg for norepinephrine and epinephririe.
Mean coefficient of interassay and control plasma variations in
78 unselected consecutive determinations with this method
were 5.1 and 12.1% for plasma NE and 5.7 and 10.1% for E.
PRA was measured by the radioimmunoassay method of Sea-
ley, Gerten-Banes, and Laragh [11] with antiserum provided by
Endocrine Sciences (Tarzana, California), the '251-angiotensin I
from New England Nuclear (Boston, Massachusetts) and the
angiotensin I standard by Cal BioMed (San Diego, California).
The interassay coefficient of variability for PRA was 7.3% for
40 consecutive determinations. Plasma aldosterone was mea-
sured by the radioimmunoassay of McKenzie and Clements [121
using commercial kits (Diagnostic Product Corporation, Los
Angeles, California). The interassay coefficient of variability
was 11.6% for 17 consecutive determinations. The data were
evaluated statistically by one way analysis of variance (Anova)
for comparisons between means, by paired or unpaired Stu-
dent's t test, by regression analysis, and by chi-square. The data
are expressed as means SEM.
Results
Table 1 provides the data on the serum concentrations and
urinary excretions of sodium and potassium, hematocrit, creati-
nine clearance, and body weight observed during the last day of
each of the study periods. It is evident that urinary excretion on
day 7 of each study was not different from sodium intake, and
the patients were, therefore, in sodium balance. The ingestion
of 100 or 200 mEq of sodium per day resulted in a significant
increment in body weight, both in normal subjects and in
patients with essential hypertension. But both the absolute
(Table 1) and the percent change (Fig. 1) in body weight were
not different among the groups.
The summary of the data on MBP, heart rate, plasma NE, E,
aldosterone, and PRA during supine position in all 20 patients
with essential hypertension and 10 normal subjects is given in
Table 2. Mean blood pressure was not different in hypertensives
and in normal subjects during low sodium intake (87 1.4 and
90 2.1 mm Hg, respectively). But, it increased significantly in
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Table 1. Serum concentration of sodium and postassium, 24-hours urinary excretion of sodium (UNaV) and potassium (UKV), body weight,
hematocrit, and endogenous creatinine clearance (Cc) in 10 normal subjects, 12 salt-sensitive (SALT-SI and 8 salt-resistant (SALT-R)
hypertensive-patients during ingestion of 10, 100. or 200 mEq of sodium per day'
10 mEq Sodium 100 mEq Sodium 200 mEq Sodium
Serum sodium5, mEqlliter
Normal subjects 137 0.6 139 0.9 139 0.7
Salt-S 137 0.5 139 0.5 139 0.5
SaIt-R 138 1.5 140 0.8 139 0.9
One-way Anova NS NS NS
Serum potassiumb, mEqlliter
Normal subjects 4.6 0.19 4.4 0.08 4.5 0.11
Salt-S 4.4 0.10 4.2 0.09 4.3 0.07
Salt-R 4.4 0.07 4.3 0.11 4.2 0.11
One-way Anova NS NS NS
UNV, mEq/24 hr
Normal subjects Ii 2.1 101 7.1 196 13
Salt-S 14 2.0 102 6.8 195 18
Salt-R 14 4.4 89 7.9 209 20
One-way Anova NS NS NS
UKV, mEqI24 hr
Normal subjects 75 6.1 74 5.6 71 9.3
Salt-S 81 5.2 68 4.0 65 5.2
Salt-R 74 7.7 64 4.4 82 8.7
One-way Anova NS NS NS
Body weight, kg
Normal subjects (changes in weight) 62.6 3.31 63.2
(0.5
3.33
0.15)
63.7
(1.1
3.33
0.16)
Salt-S (changes in weight) 74.0 4.24 74.8
(0.8
4.19
0.24)
75.5
(1.5
4.33
0.26)
Salt-R (changes in weight) 70.0 1.87 70.9
(0.8
1.89
0.34)
71.3
(1.3
1.82
0.30)
One-way Anova NS NS NS
Hematocrit", %
Normal subjects 41.4 0.79 39.8 0.90 39.9 0.87
Salt-S 41.4 1.16 40.8 1.58 41.4 1.59
Salt-R 41.3 1.28 40.3 1.19 38.6 1.66
One-way Anova NS NS NS
Cr, mlIminlI.73 m2
Normal subjects 119 8.0 128 12.4 129 11.3
Salt-S 104 5.7 112 7.1 112 7.6
Salt-R 101 9.6 113 10.1 115 11.1
One-way Anova NS NS NS
'Data are expressed as means SEM.
Measurements were obtained after subjects had rested in the supine position for 1 hour.
patients with hypertension (from 90 2.1 to 101 2.2 mm Hg,
P < 0.01) but not in normal subjects (from 87 1.4 to 86 1.7
mm Hg), when they were ingesting the high sodium diet. The
percent change in MBP was + 12.5 2.6 in all hypertensive
patients and —0.8 1.5 in normal subjects (P < 0.01), (Fig. 2).
Twelve patients showed an increment in MBP greater than the
highest rise in normal subjects (Fig. 2), that is, equal or greater
than 10%. These are arbitrarily designated "salt-sensitive pa-
tients," whereas in the remaining 8 patients the changes in MBP
were not different than in normal subjects and, therefore, are
designated "salt-resistant patients." Heart rate decreased sig-
nificantly (P < 0.05) during high sodium intake in normal
A subjects but not in salt-sensitive or salt-resistant patients.A Baseline plasma NE levels were not different among normal
subjects (22.0 3.36 ng/dl), salt-sensitive (19.8 1.86 ng/dl),Salt resistant
and salt-resistant patients (17.2 4.48 ng/dl) during low sodium
intake. They were, however, significantly greater (P <0.05) in
salt-sensitive (21.9 3.19 ng/dl) than in salt-resistant patients
(12.5 2.36 ng/dl) and in normal subjects (12.0 2.27 ng/dl)
during high sodium intake. When comparing the values of
3
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Fig 1. Percent changes in body weight in normal subjects and salt-
sensitive or salt-resistant patients with essential hypertension compar-
ing the values obtained during high sodium intake (200 mEqlday) with
those obtained during low sodium intake (10 mEqiday).
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Table 2. Mean blood pressure (MBP), heart rate, plasma norepinephrine, epinephrine, plasma renin activity (PRA), and plasma aldosterone in
12 salt-sensitive (SALT-S) patients, in 8 salt-resistant (SALT-R) patients and in 10 normal subjects during ingestion of 10, 100, or 200 mEq of
sodium per day, and after being supine I hr"
10 mEq Sodium 100 mEq Sodium 200 mEq Sodium
MBP, mm Hg
Normal subjects 87 1.4 86 1.5 86 1.7
Salt-S 88 2.4 93 3.0 104 1.9
Salt-R 94 3.6 92 5.0 97 4.3
One-way Anova NS <0.05 <0.01
Heart rate, beats/mm
Normal subjects 68 2.0 63 1.5 61 2.0
Salt-S 66 2.7 65 2.6 67 3.1
Salt-R 69 2.3 66 2.7 65 3.0
One-way Anova NS NS NS
Norepinephrine, ng/d!
Normal subjects 22.0 3.36 14.0 2.00 12.0 2.27
Salt-S 19.8 1.86 16.7 1.54 21.9 3.19
Salt-R 17.2 4.48 17.3 3.73 12.5 2.36
One-way Anova NS NS <0.05
Epinephrine, ng/d/
Normal subjects 4.70 0.75 2.30 0.47 1.95 0.41
Salt-S 1.56 0.30 2.50 0.97 1.87 0.30
SaIt-R 2.20 0.65 1.90 0.66 1.61 0.86
One-way Anova <0.01 NS NS
PRA, nglml/hr
Normal subjects 5.6 1.17 1.90 0.31 1.50 0.37
Salt-S 3.6 0.64 1.70 0.32 1.32 0.17
Salt-R 5.2 1.19 2.10 0.84 1.28 0.28
One-way Anova NS NS NS
Aldosterone, ng/dl
Normal subjects 23 3.4 11 0.9 9 0.8
Salt-S 23 3.7 11 1.6 7 0.8
Salt-R 21 3.6 8 1.5 7 1.3
One-way Anova NS NS NS
Values are the means SEM.
plasma NE levels during low sodium with those during high
sodium diet, we found that they decreased in all normal subjects
(P < 0.01) and in 7 of the 8 salt-resistant patients (P < 0.05) but
increased in 7 of 12 salt-sensitive patients (Fig. 3). There was a
significant and direct correlation (r = 0.49, P < 0.01) between
the change in plasma NE and the change in MBP observed
during the change from low to high sodium intake in all subjects
studied. Plasma NE levels were correlated inversely with
urinary sodium in normal subjects (P < 0.01) but not in patients
with essential hypertension (Fig. 4), and the majority of the salt-
sensitive patients had values of plasma NE inappropriately high
for their sodium excretion during the ingestion of high sodium
diet.
There was a significant direct correlation between baseline
MBP and plasma NE in all patients with essential hypertension
(r = 0.41, P < 0.01). This correlation was present during low (r
= 0.47, P < 0.05), medium (r 0.49, P < 0.05), or high (r =
0.47, P <0.01) sodium intake.
The summary of the data on plasma NE and E and PRA
during upright posture is given in Table 3. During upright
posture, plasma NE increased in both normal subjects and in
patients with essential hypertension, reaching a peak between
15 and 20 mm. This occurred with all regimens of sodium
intake. The increments in NE during the first 5 mm of standing
were significantly higher (P < 0.01 - 0.05 by Anova) during low
and high sodium intake in salt-sensitive patients (42 7.0 and
30 4.3 ng/dl) than in salt-resistant patients (31 4.4 and 14
3.4 ngldl) or normal subjects (20 4.8 and 18 3.1 ng/dl) (Fig.
5).
Plasma E levels (Tables 2 and 3) during low salt intake were
significantly (P < 0.01) lower in both salt-sensitive or salt-
resistant patients than they were in normal subjects. During
high salt intake, plasma E levels did not fall in salt-sensitive or
resistant patients, but they decreased significantly in normal
subjects (from 4.7 0.75 to 1.95 0.41 ngldl, P < 0.01). There
were no significant increments in plasma E during upright
posture in normal subjects during all sodium intake regimens
whereas salt sensitive or resistant patients displayed significant
increments in plasma E during upright posture.
Plasma renin activity was not different between normal
subjects and salt-sensitive patients in the supine position. PRA,
however, was lower (P < 0.01) in salt-sensitive than in salt-
resistant patients or normal subjects at 15, 20, and 60 mm of
upright posture during low sodium intake (Table 3). Seven
hypertensive patients had low, two had high, and eleven had
normal PRA according to our nomogram constructed from the
relationship between PRA measured after 1 hour of ambulation
and 24-hour urinary sodium excretion in 60 normal subjects.
Among the salt-sensitive patients, 5 had low, 1 had high, and 6
had normal PRA. Among the salt-resistant patients, 2 had low,
1 had high, and 5 had normal PRA. The differences in PRA
among salt-sensitive and resistant patients are not related to
differences in age or sex of the two subgroups but may be due to
the larger number of blacks among the salt-sensitive patients.
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A increments in MBP. Similar observations have been previously
reported by other investigators in man [7, 15] and in the Dahi's
AAA rats [8].
A The mechanisms responsible for this different behavior of the
AA patients with essential hypertension in response to sodium
intake are not fully understood. Theoretically, at least three
factors could play a role in this phenomenon. These include a
A greater sodium retention and consequent increment in body
Salt resistant
weight, impaired suppressibility of the renin-angiotensin-aldos-
terone system, and/or abnormal response of the sympathetic
nervous system. Other possibilities, not evaluated in this study,
are differences in vascular reactivity [161 and/or abnormalities
of Na-K-ATPase [17].
Kawasaki et al [7] and Fujita et al [15] reported that salt-
sensitive patients retained greater amounts of sodium and had
significantly higher body weight than did the salt-sensitive
patients by the end of 6 to 7 days of high sodium intake (240
mEq/day). They assumed that the salt-sensitive patients have
abnormal renal handling of sodium and the increase in MBP
during salt loading is due to sodium retention. Unfortunately,
these investigators did not have control data from normal
subjects. This is critical because the pattern of change in body
weight displayed by their salt-sensitive patients is similar to
previously reported data in normal subjects [18]. Indeed, during
sodium loading, normal individuals retain sodium and reach a
balance state after 3 to 5 days when they have greater body
weight but no significant change in blood pressure [18]. Our
results demonstrate that salt-sensitive patients do not differ
from normal subjects in relation to their sodium excretion and
body weight.
The data of Kawasaki et al [7] would suggest that salt-
resistant patients may have exaggerated natriuresis after 5 to 6
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obtained during high sodium intake (200 mEqiday) were compared with
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Fig 4. Correlation between supine plasma norepinephrine levels (ng/dl)
and urinary sodium excretion (mEq/day) in normal subjects (0) and in
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Fig 3. Changes (A) in supine plasma norepinephrine levels (ngldl) in
normal subjects, and salt-sensitive or salt-resistant patients with essen-
tial hypertension, when the values obtained during high sodium diet
were compared with those during low sodium intake.
The age of the salt-sensitive patients was 47 2.5 years and of
the salt-resistant patients 49 3.5 years, and the male to female
ratio was 7:5 in the salt-sensitive and 4:4 in the salt-resistant
patients. There were 6 blacks, 5 whites and 1 oriental among the
salt-sensitive patients whereas in the salt-resistant groups there
was 1 black and 7 whites.
There were no significant differences between the plasma
aldosterone levels during the supine state in normal subjects
and patients with essential hypertension (Table 3).
Discussion
Our data demonstrate, as others have shown [13, 14], that
high sodium intake of up to 200 to 250 mEq/day is not
associated with an increase in MBP in normal subjects. We
have also found that patients with essential hypertension fall
into two subgroups, with 40% being resistant to high sodium
intake and not displaying a rise in MBP, whereas the remaining
60% are sensitive to high sodium intake and display significant
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days of sodium loading. Our data do not support this conten-
tion. We found that there were no significant differences in
body weight between normal subjects and salt-sensitive or salt-
resistant patients during high sodium intake, and all were in
sodium balance (that is, sodium excretion equals intake) by the
end of day 7 of the high sodium regimen.
Our results also argue against impaired suppressibility of the
renin-aldosterone system as the mechanism for the observed
differences in the blood pressure response to high sodium intake
in patients with essential hypertension. First, there were no
significant differences in the basal levels of PRA and aldoster-
one between normal subjects and salt-sensitive or salt-resistant
patients during all regimens of sodium intake. Second, PRA
increased significantly with upright posture in all subjects, but
the increments were significantly lower in salt-sensitive patients
during both low or high sodium intake (Fig. 6).
There is a substantial body of evidence supporting the
important role that the sympathetic nervous system activity
plays in the pathogenesis of essential hypertension [19—25]. It is
also well established that high sodium intake is associated with
a fall in blood levels of catecholamines during basal conditions
in normal subjects [13, 14], and there is a significant inverse
relationship between plasma levels of NE and urinary sodium
excretion [13, 261. It is, therefore, possible that abnormal
response in the sympathetic nervous system to high sodium
intake in salt-sensitive patients is responsible for the increase in
Table 3. Plasma levels of norepinephrine, epinephrine, and PRA during upright posture in 10 normal subjects, 12 salt-sensitive (SALT-S) and 8
salt-resistant (SALT-R) patients with essential hypertension during ingestion of 10, 100, or 200 mEq of sodium per daya
Upright posture
Supine 1 hr 5 mm 10 mm 15 mm 20 mm 60 mm
Norepinephrine, 10 mEq sodium
Normal subjects 22.0 3.36 42.1 7.05" 47.8 8.42" 55.7 7.83" 50.3 8.64" 45.6 5.02"
Salt-S 19.8 1.86 62.4 8.44" 64.8 10.4" 66.4 11.65" 64.2 10.8" 60.4 8.94"
Salt-R 17.2 4.48 48.4 7.80" 45.9 7.06" 48.9 8.58" 45.9 9.43" 45.9 8.13"
One-way Anova NS NS NS NS NS NS
Norepinephrine, 100 mEq sodium
Normal subjects 14.0 2.00 30.6 4.33" 36.7 3.53" 36.2 3.98" 40.6 2.88" 44.8 4.28"
Salt-S 16.7 1.54 47.6 5.70" 54.6 8.17" 60.1 9.57" 62.1 9.82" 58.2 8.63"
SaIt-R 19.3 3.93 35.8 5.29" 42.7 9.12" 40.3 7.43" 37.6 6.52" 36.3 8.10"
One-way Anova NS NS NS NS <0.05 NS
Norepinephrine, 200 mEq sodium
Normal subjects 12.0 2.27 30.3 4.33" 40.0 5.20" 42.5 5.55" 42.6 5.17" 42.9 4.21"
Salt-S 21.9 3.19 52.1 6.31" 52.6 6.22" 56.5 6.93" 51.8 6.73" 55.6 5.61"
Salt-R 12.5 2.36 26.7 5.05" 33.3 5.41" 37.3 3.29" 33.3 4.99" 32.3 6.22"
One-way Anova <0.05 <0.05 NS NS NS <0.05
Epinephrine. 10 mEq sodium
Normal subjects 4.7 0.75 3.8 0.60 4.8 0.95 4.8 1.09 4.6 0.90 5.1 1.49
Salt-S 1.6 0.30 3.1 0.58" 3.6 0.50" 4.5 0.73" 5.4 0.88" 5.3 1.46"
Salt-R 2.2 0.65 2.9 0.60 3.2 0.73 4.9 1.53 6.9 3.24 4.4 0.97
One-way Anova <0.01 NS NS NS NS NS
Epinephrine, 100 mEq sodium
Normal subjects 2.3 0.47 4.7 1.75 4.4 1.84 4.7 1.96 4.7 1.22 4.1 0.64
Salt-S 2.5 0.97 3.5 0.93 4.7 1.05" 5.3 1.18" 6.5 1.88 3.8 0.62
Salt-R 1.9 0.66 3.4 0.86 4.6 1.62 4.2 1.34" 7.4 3.39 3.7 1.03
One-way Anova NS NS NS NS NS NS
Epinephrine, 200 mEq sodium
Normal subjects 1.95 0.41 3.1 1.22 3.6 0.94 3.8 0.95 3.7 0.73 3.0 0.56
Salt-S 1.87 0.30 3.4 0.60" 4.4 0.80" 4.7 1.12" 4.5 0.73" 4.6 0.69"
Salt-R 1.61 0.86 3.1 1.34" 4.4 0.92" 5.0 2.15" 6.7 2.40" 5.5 1.18"
One-way Anova NS NS NS NS NS NS
PRA, 10 mEq sodium
Normal subjects 5.6 1.17 6.4 1.32" 9.7 2.18" 11.8 2.21" 11.9 1.68" 16.3 2.41"
Salt-S 3.6 0.64 4.7 0.89" 5.5 1.07" 6.2 1.08" 6.9 1.20" 7.3 1.24"
Salt-R 5.2 1.19 7.1 1.74 11.1 2.49" 16.8 5.27" 15.6 4.41" 15.9 3.40"
One-Way Anova NS NS NS <0.05 <0.05 <0.05
PRA, 100 mEq sodium
Normal subjects 1.9 0.31 2.4 0.33" 3.5 0.54" 5.1 0.86" 5.7 0.95" 7.4 0.99"
Salt-S 1.7 0.32 1.6 0.28 2.3 0.37" 2.6 0.48" 3.0 0.54" 2.9 0.59"
Salt-R 2.1 0.84 2.7 0.98" 3.6 1.15" 4.5 1.26" 5.8 1.60" 6.1 1.52"
One-way Anova NS NS NS NS NS <0.01
PRA, 200 mEq sodium
Normal subjects 1.5 0.37 1.9 0.50" 2.6 0.63" 3.1 0.64" 3.8 0.78" 5.3 0.84"
Salt-S 2.1 0.90 2.2 0.93 2.6 0.97" 3.0 1.31" 3.1 1.21" 3.0 1.18"
Salt-R 1.3 0.28 1.5 0.30h 1.8 0.34" 2.5 0.56" 3.0 0.78" 3.7 0.56"
One-way Anova NS NS NS NS NS NS
a Values are means 5EM.
"Compared to the values after supine 1 hour, P < 0.05.
"Compared to the values after supine 1 hour, P < 0.01.
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FigS. Increments in plasma norepinephrine levels (ng/dl) during upright
posture in normal subjects (0) and salt-sensitive (A) or salt-resistant
patients (A) ingesting low (10 mEq/day). or high (200mEq/day) sodium
intake.
Low sodium High sodium
o.---..o Normal subjects
'-——-Salt sensitive
- Salt resistant
-
0 10 20 30 40 50600 10 20 30 40 50 60
Time in upright posture, rn/n
Fig 6. Increments in plasma renin activity (PRA, nglrnl/hr) during
upright posture in normal subjects (0) and salt-sensitive (A) or sal/-
resistant patients (A) ingesting low (10 mEq/day) or high (200 mEq/day)
sodium intake.
their MBP. Fujita et al [15] found that salt-sensitive patients
with essential hypertension displayed a significant fall in their
plasma NE after 3 days of high sodium intake but plasma NE
increased again by day 4; they suggested that the persistance of
autonomic drive may contribute to the rise in MBP during high
sodium intake in these patients.
Several lines of evidence in our data make the above-
mentioned hypothesis plausible. First, although the basal plas-
ma levels of NE were not significantly different among all
subjects during low sodium intake, they decreased significantly
during high sodium intake only in salt-resistant patients and in
normal subjects. Thus, plasma NE during high sodium intake
was significantly higher in the salt-sensitive patients than in the
other subjects. Second, the correlation between plasma NE and
urinary sodium excretion demonstrates that the majority of salt-
sensitive patients have inappropriately high plasma NE in
relation to their urinary excretion of sodium during high sodium
intake; they could be categorized as having "high NE hyperten-
sion." Third, the increments in plasma NE after 5 mm of
standing were significantly higher in salt-sensitive patients than
in salt-resistant patients and normal subjects during both low or
high sodium intake (Fig. 5). This observation is consistent with
hyperresponsiveness of the sympathetic nervous system to
upright posture in these patients. One should emphasize that
the differences in the plasma levels of NE were not related to
variations in the sequence of the salt regimen. For example,
among the 7 salt-sensitive patients who had higher plasma NE
during high sodium intake, the sequence of sodium regimen was
as follows: 4 patients started with low sodium intake followed
by medium and then high intake in 2 and by high and then
medium intake in 2; two patients started with high intake
followed by medium and then low intake in 1 and by low and
medium intake in the other; and 1 patient started with medium
intake followed by low and high intake.
Thus, our data suggests that a subset of patients with
essential hypertension may have impaired suppressibility of
plasma norepinephrine levels during high sodium intake and
exaggerated rise during orthostasis. These aberrations may be
responsible for the increase in MBP during high sodium intake.
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